NCT04874818View on ClinicalTrials.gov

CD8+ T-cell PET/CT Imaging in COVID-19 Patients

TerminatedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Lymphopenia Due to COVID-19T-cellPET Imaging
Interventions
DIAGNOSTIC_TEST

[89Zr]Df-IAB22M2C PET/CT scan

PET imaging procedure

Trial Locations (1)

6500HB

Radboud university medical center, Nijmegen

Sponsors

Collaborators (1)

ImaginAb, Inc.
All Listed Sponsors
collaborator

ImaginAb, Inc.

INDUSTRY

lead

Radboud University Medical Center

OTHER

NCT04874818 - CD8+ T-cell PET/CT Imaging in COVID-19 Patients | Biotech Hunter | Biotech Hunter